| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |